Tiansheng Pharmaceutical Group Co Ltd (002872) — Tangible Net Worth Ratio
Tiansheng Pharmaceutical Group Co Ltd (002872) has a Tangible Net Worth Ratio of 85.9% as of September 2025. This metric is calculated by deducting intangible assets (CN¥277.41 Million) from net assets (CN¥1.97 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 002872 net asset value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tiansheng Pharmaceutical Group Co Ltd Tangible Net Worth Ratio (2012–2024)
This chart shows how Tiansheng Pharmaceutical Group Co Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 85.9%, reflecting net assets of CN¥1.97 Billion with intangible assets of CN¥277.41 Million CNY. Also explore how fast is Tiansheng Pharmaceutical Group Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Tiansheng Pharmaceutical Group Co Ltd (2012–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of Tiansheng Pharmaceutical Group Co Ltd.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 85.8% | CN¥2.01 Billion | CN¥285.90 Million | CN¥2.74 Billion | ▲ +0.7 pp |
| 2023 | 85.1% | CN¥2.10 Billion | CN¥311.77 Million | CN¥2.81 Billion | ▼ -0.3 pp |
| 2022 | 85.4% | CN¥2.19 Billion | CN¥319.50 Million | CN¥2.97 Billion | ▼ -0.3 pp |
| 2021 | 85.6% | CN¥2.28 Billion | CN¥327.14 Million | CN¥3.12 Billion | ▲ +1.1 pp |
| 2020 | 84.6% | CN¥2.39 Billion | CN¥368.72 Million | CN¥3.65 Billion | ▼ -0.9 pp |
| 2019 | 85.5% | CN¥2.95 Billion | CN¥427.89 Million | CN¥4.39 Billion | ▼ -0.8 pp |
| 2018 | 86.3% | CN¥3.18 Billion | CN¥435.49 Million | CN¥4.67 Billion | ▼ -0.6 pp |
| 2017 | 86.9% | CN¥3.19 Billion | CN¥418.22 Million | CN¥4.95 Billion | ▲ +8.2 pp |
| 2016 | 78.7% | CN¥1.86 Billion | CN¥395.48 Million | CN¥3.39 Billion | ▲ +1.4 pp |
| 2015 | 77.3% | CN¥1.63 Billion | CN¥369.63 Million | CN¥2.87 Billion | ▼ -1.2 pp |
| 2014 | 78.5% | CN¥1.43 Billion | CN¥307.16 Million | CN¥2.50 Billion | ▲ +4.5 pp |
| 2013 | 74.1% | CN¥1.08 Billion | CN¥279.43 Million | CN¥2.16 Billion | ▲ +3.8 pp |
| 2012 | 70.3% | CN¥951.66 Million | CN¥282.87 Million | CN¥1.74 Billion | — |